Learn the basics of embedded systems hacking with Arduino, Raspberry Pi & RTOS. Discover GPIO, interrupts, hands-on projects ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

As Tubulis prepares to unveil the first in-human data on its next-generation antibody drug conjugate (ADC) later this month, ...

The African Democratic Congress has issued an ultimatum to former Vice President Atiku Abubakar, former Secretary to the Government of the Federation, Babachir Lawal, and other prominent figures in ...

The Chairman of the African Democratic Congress, ADC, in Lagos State, George Ashiru, on Friday explained why the party asked the likes of former Vice President Atiku Abubakar, Nasir El-Rufai, Rotimi ...

Former President Goodluck Jonathan on Thursday night, met with the National Chairman of the coalition African Democratic Congress, ADC, David Mark. The meeting came shortly after Mark, former vice ...

REDMOND, Wash., Sept. 24, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan) and ...

The African Democratic Congress (ADC) has said the demand by Nigeria for a permanent seat on the United Nations Security Council won’t be taken seriously because the government has failed to secure ...

Step-by-step builds beat full-spec instructions for AI coding. AIs can destroy code as quickly as they create it. Use AGENTS.md, screenshots, and refactoring to keep projects stable. Last week, I put ...

We are now nearly one week into the saga that has taken Jimmy Kimmel Live! off of ABC’s airwaves, and Tuesday night will bring new developments. Disney announced on Monday that Jimmy Kimmel’s show ...

ABUJA – The African Democratic Congress (ADC) has rejected the Presidency’s assurance that President Bola Tinubu has no plan to extend his stay in office beyond 2031, insisting that his constitutional ...

Jiangsu Hengrui Pharmaceuticals’ dealmaking spree rolls on, with a potential $1.1 billion transaction on a rival to AstraZeneca and Daiichi Sankyo’s blockbuster Enhertu being the latest addition.